Used in pharmaceutical research, particularly as a key intermediate in the synthesis of compounds with potential for treating neurological disorders such as Alzheimer's or Parkinson's disease. Its pyrrolidine-like structure enables it to cross the blood-brain barrier, making it valuable for development as an acetylcholinesterase enzyme inhibitor or nicotinic receptor agonist. This helps in modulating central nervous system function. Additionally, it is studied for anti-inflammatory and antioxidant effects at the cellular level.